Intra-Cellular TherapiesITCI
13F holders, Q3 2025 (September 30)1holders −2
0new positions
2sold out
$2540.00avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Intra-Cellular Therapies Inc. (ITCI) in their 13F filings, down 2 from Q2 2025. 0 opened new positions and 2 sold out. The largest holder was Huntington National Bank ($3K).
- Company
- Intra-Cellular Therapies Inc.
- CUSIP
- 46116X101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $4.1M |
All 13F filers, Q2 2025 → Q3 2025: 52,794 shares sold, net −52,794 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Huntington National Bank | 0.00% | No change | 1 | $3K |
"% of holder's portfolio" is ITCI's weight in each manager's 13F, not the share of Intra-Cellular Therapies Inc. the manager owns.